Marker Therapeutics Inc (MRKR) — Cash Flow-to-Debt Ratio
Marker Therapeutics Inc (MRKR) has a Cash Flow-to-Debt Ratio of -0.39x as of March 2026, meaning its operating cash flow of $-1.40 Million could theoretically repay 0% of its total liabilities ($3.64 Million) in one year. Check MRKR cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Marker Therapeutics Inc Cash Flow-to-Debt Ratio (1999–2025)
Historical debt coverage capacity for Marker Therapeutics Inc across 27 annual periods. Also explore MRKR current and non-current assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Marker Therapeutics Inc (1999–2025)
Year-by-year debt coverage analysis for Marker Therapeutics Inc. For market capitalisation and broader financial context, see Marker Therapeutics Inc market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -5.28x | $-12.01 Million | $2.27 Million | ▼ -67.7% |
| 2024 | -3.15x | $-10.91 Million | $3.46 Million | ▲ +41.1% |
| 2023 | -5.35x | $-16.44 Million | $3.07 Million | ▼ -193.8% |
| 2022 | -1.82x | $-26.97 Million | $14.82 Million | ▼ -61.1% |
| 2021 | -1.13x | $-27.28 Million | $24.15 Million | ▼ -3.0% |
| 2020 | -1.10x | $-20.03 Million | $18.27 Million | ▲ +86.4% |
| 2019 | -8.04x | $-18.28 Million | $2.27 Million | ▼ -55.7% |
| 2018 | -5.16x | $-14.48 Million | $2.80 Million | ▲ +6.8% |
| 2017 | -5.54x | $-8.44 Million | $1.52 Million | ▼ -47.9% |
| 2016 | -3.75x | $-6.51 Million | $1.74 Million | ▼ -2316.8% |
| 2015 | -0.16x | $-4.34 Million | $28.01 Million | ▲ +91.1% |
| 2014 | -1.75x | $-2.19 Million | $1.25 Million | ▼ -2131.6% |
| 2013 | -0.08x | $-694.58K | $8.85 Million | ▲ +71.0% |
| 2012 | -0.27x | $-1.57 Million | $5.77 Million | ▲ +21.3% |
| 2011 | -0.34x | $-1.31 Million | $3.80 Million | ▼ -26.3% |
| 2010 | -0.27x | $-925.04K | $3.39 Million | ▲ +76.0% |
| 2009 | -1.14x | $-1.12 Million | $986.35K | ▼ -389.7% |
| 2008 | -0.23x | $-714.42K | $3.08 Million | ▲ +63.0% |
| 2007 | -0.63x | $-1.23 Million | $1.95 Million | ▼ -66.9% |
| 2006 | -0.38x | $-1.19 Million | $3.15 Million | ▲ +25.5% |
| 2005 | -0.50x | $-1.16 Million | $2.31 Million | ▼ -4.9% |
| 2004 | -0.48x | $-1.21 Million | $2.53 Million | ▲ +86.3% |
| 2003 | -3.52x | $-2.59 Million | $736.95K | ▲ +26.1% |
| 2002 | -4.76x | $-1.41 Million | $295.60K | ▼ -34741.2% |
| 2001 | 0.01x | $2.38K | $173.03K | ▲ +101.1% |
| 2000 | -1.29x | $-879.74K | $682.74K | ▲ +54.2% |
| 1999 | -2.81x | $-815.18K | $289.71K | — |